mk 0591 has been researched along with Colitis, Ulcerative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukhave, K; Depré, M; Friedman, BS; Hillingsø, J; Kjeldsen, J; Lauritsen, K; Laursen, LS; Malmström, K; Shingo, S; von Spreckelsen, S | 1 |
| Berger, ML; Berlin, RG; Cagliola, A; Haggitt, RC; Hanauer, SB; Reagan, JE; Roberts, WG; Simon, S; Simon, TJ; Snyder, ES; Stenson, WF; Tanaka, WK | 1 |
2 trial(s) available for mk 0591 and Colitis, Ulcerative
| Article | Year |
|---|---|
Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
Topics: Acute Disease; Administration, Oral; Adult; Colitis, Ulcerative; Dinoprostone; Double-Blind Method; Female; Humans; Indoles; Leukotriene B4; Male; Middle Aged; Quinolines | 1995 |
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Colitis, Ulcerative; Double-Blind Method; Female; Humans; Indoles; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Quinolines | 1997 |